{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:12:13Z","timestamp":1780398733743,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2017YFC1310103"],"award-info":[{"award-number":["2017YFC1310103"]}]},{"name":"the STI2030-Major Projects","award":["2021ZD0201802"],"award-info":[{"award-number":["2021ZD0201802"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04636-8","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:36:12Z","timestamp":1768559772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating adipokines level and the risk of neurodegenerative diseases: a two\u2011sample mendelian randomization study and proteomic analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Wenxian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heya","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boye","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuibai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"4636_CR1","doi-asserted-by":"publisher","unstructured":"Ricci C. Neurodegenerative disease: from molecular basis to therapy. Int J Mol Sci. 2024;25(2). https:\/\/doi.org\/10.3390\/ijms25020967.","DOI":"10.3390\/ijms25020967"},{"key":"4636_CR2","doi-asserted-by":"publisher","unstructured":"Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10(4). https:\/\/doi.org\/10.1101\/cshperspect.a033118.","DOI":"10.1101\/cshperspect.a033118"},{"key":"4636_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s1474-4422(15)00110-6","volume":"14 7","author":"D Mohammadi","year":"2015","unstructured":"Mohammadi D. Fast-forwarding treatment for neurodegenerative disorders. Lancet Neurol. 2015;14 7:687\u20138. https:\/\/doi.org\/10.1016\/s1474-4422(15)00110-6.","journal-title":"Lancet Neurol"},{"key":"4636_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07185-7","author":"MS Haney","year":"2024","unstructured":"Haney MS, P\u00e1lovics R, Munson CN, Long C, Johansson PK, Yip O, et al. APOE4\/4 is linked to damaging lipid droplets in alzheimer\u2019s disease microglia. Nature. 2024. https:\/\/doi.org\/10.1038\/s41586-024-07185-7.","journal-title":"Nature"},{"key":"4636_CR5","doi-asserted-by":"publisher","unstructured":"Cerasuolo M, Di Meo I, Auriemma MC, Paolisso G, Papa M, Rizzo MR. Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer\u2019s Disease. Biomolecules. 2024;14(11). https:\/\/doi.org\/10.3390\/biom14111362.","DOI":"10.3390\/biom14111362"},{"key":"4636_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms20225638","volume":"20","author":"TH Lee","year":"2019","unstructured":"Lee TH, Cheng KK, Hoo RL, Siu PM, Yau SY. The novel perspectives of adipokines on brain health. Int J Mol Sci. 2019;20:22. https:\/\/doi.org\/10.3390\/ijms20225638.","journal-title":"Int J Mol Sci"},{"key":"4636_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neurobiolaging.2012.08.003","volume":"34 1","author":"GH Doherty","year":"2013","unstructured":"Doherty GH, Beccano-Kelly D, Yan SD, Gunn-Moore FJ, Harvey J. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid \u03b2. Neurobiol Aging. 2013;34 1:226\u201337. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.08.003.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4636_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","volume":"13","author":"A Parimisetty","year":"2016","unstructured":"Parimisetty A, Dorsemans AC, Awada R, Ravanan P, Diotel N, Lefebvre d\u2019Hellencourt C Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation. 2016;13(1):67. https:\/\/doi.org\/10.1186\/s12974-016-0530-x.","journal-title":"J Neuroinflammation"},{"key":"4636_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fnins.2019.00378","volume":"13","author":"X Zou","year":"2019","unstructured":"Zou X, Zhong L, Zhu C, Zhao H, Zhao F, Cui R, et al. Role of leptin in mood disorder and neurodegenerative disease. Front Neurosci. 2019;13:378. https:\/\/doi.org\/10.3389\/fnins.2019.00378.","journal-title":"Front Neurosci"},{"key":"4636_CR10","doi-asserted-by":"publisher","unstructured":"Milanowski J, Kozerawski K, Fal\u0119cka W, Dudek D, Lisewska B, Lisewski P, et al. Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson\u2019s Disease-Preliminary Studies. Metabolites. 2023;13(5). https:\/\/doi.org\/10.3390\/metabo13050668.","DOI":"10.3390\/metabo13050668"},{"issue":"1","key":"4636_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/jpet.122.001380","volume":"384","author":"DV Quaranta","year":"2023","unstructured":"Quaranta DV, Weaver RR, Baumann KK, Fujimoto T, Williams LM, Kim HC, et al. Transport of the Proinflammatory chemokines C-C motif chemokine ligand 2 (MCP-1) and C-C motif chemokine ligand 5 (RANTES) across the intact mouse Blood-Brain barrier is inhibited by heparin and eprodisate and increased with systemic inflammation. J Pharmacol Exp Ther. 2023;384(1):205\u201323. https:\/\/doi.org\/10.1124\/jpet.122.001380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4636_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3233\/jad-215063","volume":"85","author":"XD Yan","year":"2022","unstructured":"Yan XD, Qu XS, Yin J, Qiao J, Zhang J, Qi JS, et al. Adiponectin ameliorates cognitive behaviors and in vivo synaptic plasticity impairments in 3xTg-AD mice. J Alzheimers Dis. 2022;85(1):343\u201357. https:\/\/doi.org\/10.3233\/jad-215063.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"4636_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12017-012-8201-2","volume":"15","author":"AL Teixeira","year":"2013","unstructured":"Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, et al. Decreased levels of Circulating adiponectin in mild cognitive impairment and alzheimer\u2019s disease. Neuromolecular Med. 2013;15(1):115\u201321. https:\/\/doi.org\/10.1007\/s12017-012-8201-2.","journal-title":"Neuromolecular Med"},{"key":"4636_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/ene.12915","volume":"23 3","author":"K Kitagawa","year":"2016","unstructured":"Kitagawa K, Miwa K, Okazaki S, Sakaguchi M, Mochizuki H. Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors. Eur J Neurol. 2016;23 3:641\u20137. https:\/\/doi.org\/10.1111\/ene.12915.","journal-title":"Eur J Neurol"},{"key":"4636_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1468-1331.2010.03194.x","volume":"18 7","author":"K Une","year":"2011","unstructured":"Une K, Takei YA, Tomita N, Asamura T, Ohrui T, Furukawa K, et al. Adiponectin in plasma and cerebrospinal fluid in MCI and alzheimer\u2019s disease. Eur J Neurol. 2011;18 7:1006\u20139. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03194.x.","journal-title":"Eur J Neurol"},{"key":"4636_CR16","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318 19","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S, Mendelian Randomization. JAMA. 2017;318 19:1925\u20136. https:\/\/doi.org\/10.1001\/jama.2017.17219.","journal-title":"JAMA"},{"key":"4636_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27 8","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27 8:1133\u201363. https:\/\/doi.org\/10.1002\/sim.3034.","journal-title":"Stat Med"},{"key":"4636_CR18","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/asn.2016010098","volume":"27 11","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrology: JASN. 2016;27 11:3253\u201365. https:\/\/doi.org\/10.1681\/asn.2016010098.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4636_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326 16","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326 16:1614\u201321. https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"JAMA"},{"issue":"3","key":"4636_CR20","doi-asserted-by":"publisher","first-page":"e1002607","DOI":"10.1371\/journal.pgen.1002607","volume":"8","author":"Z Dastani","year":"2012","unstructured":"Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8(3):e1002607. https:\/\/doi.org\/10.1371\/journal.pgen.1002607.","journal-title":"PLoS Genet"},{"key":"4636_CR21","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.2337\/db20-0070","volume":"69 12","author":"H Yaghootkar","year":"2020","unstructured":"Yaghootkar H, Zhang Y, Spracklen CN, Karaderi T, Huang LO, Bradfield J, et al. Genetic studies of leptin concentrations implicate leptin in the regulation of early adiposity. Diabetes. 2020;69 12:2806\u201318. https:\/\/doi.org\/10.2337\/db20-0070.","journal-title":"Diabetes"},{"key":"4636_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","volume":"2 10","author":"L Folkersen","year":"2020","unstructured":"Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman \u00c5K, Schork A, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2 10:1135\u201348. https:\/\/doi.org\/10.1038\/s42255-020-00287-2.","journal-title":"Nat Metab"},{"issue":"3","key":"4636_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nat Genet"},{"key":"4636_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/s1474-4422(19)30320-5","volume":"18 12","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18 12:1091\u2013102. https:\/\/doi.org\/10.1016\/s1474-4422(19)30320-5.","journal-title":"Lancet Neurol"},{"key":"4636_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng.3622","volume":"48 9","author":"W van Rheenen","year":"2016","unstructured":"van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48 9:1043\u20138. https:\/\/doi.org\/10.1038\/ng.3622.","journal-title":"Nat Genet"},{"key":"4636_CR26","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31 21","author":"MJ Machiela","year":"2015","unstructured":"Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinf (Oxford England). 2015;31 21:3555\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btv402.","journal-title":"Bioinf (Oxford England)"},{"key":"4636_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40 3","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40 3:755\u201364. https:\/\/doi.org\/10.1093\/ije\/dyr036.","journal-title":"Int J Epidemiol"},{"key":"4636_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7 3","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2011;7 3:270\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"4636_CR29","doi-asserted-by":"publisher","first-page":"e082404","DOI":"10.1136\/bmjopen-2023-082404","volume":"14 7","author":"P Wang","year":"2024","unstructured":"Wang P, Sun W, Gong J, Han X, Xu C, Chen Y, et al. Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study). BMJ Open. 2024;14 7:e082404. https:\/\/doi.org\/10.1136\/bmjopen-2023-082404.","journal-title":"BMJ Open"},{"key":"4636_CR30","doi-asserted-by":"publisher","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"key":"4636_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48 3","author":"J Bowden","year":"2019","unstructured":"Bowden J, Del Greco MF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48 3:728\u201342. https:\/\/doi.org\/10.1093\/ije\/dyy258.","journal-title":"Int J Epidemiol"},{"key":"4636_CR32","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36 11","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of Pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36 11:1783\u2013802. https:\/\/doi.org\/10.1002\/sim.7221.","journal-title":"Stat Med"},{"key":"4636_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50 5","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50 5:693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"key":"4636_CR34","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27 R2","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of Pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27 R2:R195\u2013208. https:\/\/doi.org\/10.1093\/hmg\/ddy163.","journal-title":"Hum Mol Genet"},{"key":"4636_CR35","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270 45","author":"PE Scherer","year":"1995","unstructured":"Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270 45:26746\u20139. https:\/\/doi.org\/10.1074\/jbc.270.45.26746.","journal-title":"J Biol Chem"},{"key":"4636_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fnagi.2019.00356","volume":"11","author":"R Chen","year":"2019","unstructured":"Chen R, Shu Y, Zeng Y. Links between adiponectin and dementia: from risk factors to pathophysiology. Front Aging Neurosci. 2019;11:356. https:\/\/doi.org\/10.3389\/fnagi.2019.00356.","journal-title":"Front Aging Neurosci"},{"key":"4636_CR37","doi-asserted-by":"publisher","first-page":"102390","DOI":"10.1016\/j.redox.2022.102390","volume":"54","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wu X, Wang J, Shi Y, Hu Q, Cui W, et al. Adiponectin\/AdiopR1 signaling prevents mitochondrial dysfunction and oxidative injury after traumatic brain injury in a SIRT3 dependent manner. Redox Biol. 2022;54:102390. https:\/\/doi.org\/10.1016\/j.redox.2022.102390.","journal-title":"Redox Biol"},{"key":"4636_CR38","doi-asserted-by":"publisher","first-page":"113302","DOI":"10.1016\/j.expneurol.2020.113302","volume":"329","author":"H Liu","year":"2020","unstructured":"Liu H, Wu X, Luo J, Zhao L, Li X, Guo H, et al. Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK\/GSK-3\u03b2. Exp Neurol. 2020;329:113302. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113302.","journal-title":"Exp Neurol"},{"key":"4636_CR39","doi-asserted-by":"publisher","first-page":"105876","DOI":"10.1016\/j.nbd.2022.105876","volume":"174","author":"M Khandelwal","year":"2022","unstructured":"Khandelwal M, Manglani K, Upadhyay P, Azad M, Gupta S. AdipoRon induces AMPK activation and ameliorates alzheimer\u2019s like pathologies and associated cognitive impairment in APP\/PS1 mice. Neurobiol Dis. 2022;174:105876. https:\/\/doi.org\/10.1016\/j.nbd.2022.105876.","journal-title":"Neurobiol Dis"},{"key":"4636_CR40","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1210\/en.2015-2078","volume":"157 7","author":"D Zhang","year":"2016","unstructured":"Zhang D, Wang X, Lu XY. Adiponectin exerts neurotrophic effects on dendritic Arborization, Spinogenesis, and neurogenesis of the dentate gyrus of male mice. Endocrinology. 2016;157 7:2853\u201369. https:\/\/doi.org\/10.1210\/en.2015-2078.","journal-title":"Endocrinology"},{"key":"4636_CR41","doi-asserted-by":"publisher","first-page":"113249","DOI":"10.1016\/j.expneurol.2020.113249","volume":"327","author":"B Liu","year":"2020","unstructured":"Liu B, Liu J, Wang JG, Liu CL, Yan HJ. AdipoRon improves cognitive dysfunction of alzheimer\u2019s disease and rescues impaired neural stem cell proliferation through AdipoR1\/AMPK pathway. Exp Neurol. 2020;327:113249. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113249.","journal-title":"Exp Neurol"},{"issue":"1","key":"4636_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-016-0136-x","volume":"11","author":"RC Ng","year":"2016","unstructured":"Ng RC, Cheng OY, Jian M, Kwan JS, Ho PW, Cheng KK, et al Chronic adiponectin deficiency leads to Alzheimer\u2019s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice. Mol Neurodegener. 2016;11(1):71. https:\/\/doi.org\/10.1186\/s13024-016-0136-x.","journal-title":"Mol Neurodegener"},{"key":"4636_CR43","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. https:\/\/doi.org\/10.1136\/bmj.k601.","journal-title":"BMJ"},{"issue":"2","key":"4636_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570161114666160905170644","volume":"15","author":"M Macesic","year":"2017","unstructured":"Macesic M, Lalic NM, Kostic VS, Jotic A, Lalic K, Stefanova E, et al. Impaired insulin sensitivity and secretion in patients with alzheimer\u2019s disease: the relationship with other atherosclerosis risk factors. Curr Vasc Pharmacol. 2017;15(2):158\u201366. https:\/\/doi.org\/10.2174\/1570161114666160905170644.","journal-title":"Curr Vasc Pharmacol"},{"key":"4636_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/gerona\/glab267","volume":"77 6","author":"SS Mooldijk","year":"2022","unstructured":"Mooldijk SS, Ikram MK, Ikram MA. Adiponectin, Leptin, and resistin and the risk of dementia. J Gerontol Biol Sci Med Sci. 2022;77 6:1245\u20139. https:\/\/doi.org\/10.1093\/gerona\/glab267.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"4636_CR46","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3233\/jad-210722","volume":"84 3","author":"H Kim","year":"2021","unstructured":"Kim H, Jun S, Kim BS, Kim IJ. Serum adiponectin in alzheimer\u2019s disease (AD): association with AD biomarkers and cognitive outcome. J Alzheimers Dis. 2021;84 3:1163\u201372. https:\/\/doi.org\/10.3233\/jad-210722.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"4636_CR47","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41467-019-11112-0","volume":"10","author":"L Duncan","year":"2019","unstructured":"Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, et al Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10(1):3328. https:\/\/doi.org\/10.1038\/s41467-019-11112-0.","journal-title":"Nat Commun"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04636-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04636-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04636-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:38:00Z","timestamp":1770831480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04636-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4636"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04636-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, for the MR analysis section, data were obtained from available genome-wide association study (GWAS) summary statistics, thus obviating the need for additional ethical approval. Proteomics analysis was approved by the Ethics Committee of Xuanwu Hospital of Capital Medical University (approval number: 2017-058).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}